Stueland will remain in an advisory role through January 2027 to help with the transition, GeneDx said Wednesday. Cunningham joined Quanterix in January as its president, CEO and a board member, making his tenure there less than a year.
Quanterix said Jim Gute, its chief commercial officer since August, will serve as interim president and CEO while the company searches for a successor. It will consider both internal and external candidates. Quanterix shares recently fell 14% to $2.45 in premarket trading.

Comments (0)
No comments yet. Be the first!